Skip to main content

Advertisement

Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial

Fig. 2

Mean visual analogue scale breathlessness scores for Groups 1 and 2. VAS, visual analogue scale; baseline, breathlessness assessment made on the first day of treatment, before nebulization. Mean visual analogue scale breathlessness scores for 8 days were calculated from visual analogue scale scores taken in fourth hour after nebulization

Back to article page